Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 5.86
-0.06 (-1.01%)
Apr 21, 2026, 3:04 PM CST
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 8.31 billion as of April 21, 2026. Its market cap has decreased by -3.90% in one year.
Market Cap
8.31B
Enterprise Value
7.78B
Revenue
765.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.86
Market Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 8.31B, an increase of 538.30%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 8.31B | -0.67% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 9.15B |
| Shanghai Medicilon | 9.14B |
| Youcare Pharmaceutical Group | 8.86B |
| Zhejiang Ausun Pharmaceutical | 8.34B |
| Jiangsu Aidea Pharmaceutical Group | 8.15B |
| Acrobiosystems | 8.05B |
| Chengdu Kanghua Biological Products | 7.77B |
| Suzhou Fengbei Biotech Stock | 7.75B |